Stock listing
Stuttgart:2PQ Organogenesis Holdings Inc. Aktie
German listing (Stuttgart) of Organogenesis Holdings Inc. · home listing NASDAQ:ORGO
Follow Organogenesis Holdings Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ORGO
$0.756 USD -0.013 (-1.6%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ORGO
- Day range
- $0.730 – $0.800 USDNov 2, 2026
- Volume
- 2.28M sharesNov 2, 2026
- Market cap
- $97.21M USDAt the close on Nov 2, 2026 · price × 128.7M shares outstanding
- 52-week range
- $0.730 – $7.077 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $1.24M USDMedian day 706,900 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ORGO · Home | $0.756 USD | -0.013 (-1.6%) | 2,279,000 | $0.780 | $0.800 | $0.730 | $0.768 | Close on Nov 2, 2026 |
| Frankfurt:2PQ | €0.685 EUR | -0.120 (-14.9%) | — | €0.730 | €0.730 | €0.675 | €0.805 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:ORGO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.756 | -0.013 | -1.6% | $0.780 | $0.800 | $0.730 | 2,279,000 | |
| $0.768 | -0.051 | -6.2% | $0.805 | $0.820 | $0.762 | 760,306 | |
| $0.819 | -0.006 | -0.7% | $0.820 | $0.863 | $0.811 | 1,006,593 | |
| $0.825 | -0.078 | -8.6% | $0.890 | $0.920 | $0.810 | 1,796,620 | |
| $0.902 | -0.033 | -3.5% | $0.935 | $0.948 | $0.894 | 876,980 | |
| $0.935 | -0.058 | -5.8% | $0.994 | $1.010 | $0.931 | 698,262 | |
| $0.993 | -0.037 | -3.6% | $1.020 | $1.030 | $0.933 | 1,338,800 | |
| $1.030 | +0.039 | +3.9% | $0.985 | $1.045 | $0.981 | 722,800 | |
| $0.991 | -0.029 | -2.8% | $1.040 | $1.060 | $0.960 | 1,150,900 | |
| $1.020 | 0.000 | 0.0% | $1.030 | $1.105 | $1.000 | 1,873,200 | |
| $1.020 | +0.020 | +2.0% | $1.010 | $1.050 | $0.929 | 989,100 | |
| $1.000 | -0.110 | -9.9% | $1.120 | $1.130 | $0.990 | 1,266,900 | |
| $1.110 | -0.030 | -2.6% | $1.140 | $1.145 | $1.100 | 782,600 | |
| $1.140 | -0.070 | -5.8% | $1.190 | $1.200 | $1.130 | 652,900 | |
| $1.210 | -0.020 | -1.6% | $1.240 | $1.240 | $1.195 | 706,900 | |
| $1.230 | -0.060 | -4.7% | $1.280 | $1.280 | $1.220 | 506,700 | |
| $1.290 | +0.010 | +0.8% | $1.280 | $1.310 | $1.270 | 402,100 | |
| $1.280 | -0.040 | -3.0% | $1.290 | $1.310 | $1.250 | 750,000 | |
| $1.320 | -0.020 | -1.5% | $1.340 | $1.390 | $1.300 | 772,000 | |
| $1.340 | +0.050 | +3.9% | $1.300 | $1.350 | $1.290 | 608,700 | |
| $1.290 | -0.040 | -3.0% | $1.320 | $1.338 | $1.275 | 1,834,400 | |
| $1.330 | -0.070 | -5.0% | $1.400 | $1.400 | $1.320 | 536,600 | |
| $1.400 | +0.030 | +2.2% | $1.380 | $1.430 | $1.370 | 684,500 | |
| $1.370 | -0.015 | -1.1% | $1.380 | $1.405 | $1.350 | 543,900 | |
| $1.385 | +0.005 | +0.4% | $1.360 | $1.404 | $1.360 | 469,600 | |
| $1.380 | -0.030 | -2.1% | $1.380 | $1.390 | $1.350 | 445,600 | |
| $1.410 | -0.010 | -0.7% | $1.430 | $1.440 | $1.360 | 603,500 | |
| $1.420 | -0.030 | -2.1% | $1.450 | $1.460 | $1.390 | 532,700 | |
| $1.450 | -0.030 | -2.0% | $1.460 | $1.470 | $1.420 | 415,600 | |
| $1.480 | +0.080 | +5.7% | $1.400 | $1.495 | $1.400 | 411,400 | |
| $1.400 | -0.020 | -1.4% | $1.410 | $1.415 | $1.380 | 355,900 | |
| $1.420 | +0.060 | +4.4% | $1.360 | $1.420 | $1.340 | 1,003,200 | |
| $1.360 | -0.030 | -2.2% | $1.420 | $1.420 | $1.355 | 506,800 | |
| $1.390 | -0.070 | -4.8% | $1.450 | $1.465 | $1.380 | 943,400 | |
| $1.460 | -0.040 | -2.7% | $1.490 | $1.495 | $1.450 | 445,100 | |
| $1.500 | +0.010 | +0.7% | $1.490 | $1.510 | $1.450 | 646,200 | |
| $1.490 | -0.040 | -2.6% | $1.560 | $1.560 | $1.470 | 844,100 | |
| $1.530 | -0.040 | -2.5% | $1.570 | $1.570 | $1.490 | 912,500 | |
| $1.570 | -0.030 | -1.9% | $1.580 | $1.590 | $1.550 | 465,700 | |
| $1.600 | -0.110 | -6.4% | $1.680 | $1.680 | $1.570 | 979,700 | |
| $1.710 | +0.070 | +4.3% | $1.650 | $1.730 | $1.625 | 665,500 | |
| $1.640 | -0.030 | -1.8% | $1.690 | $1.695 | $1.590 | 561,500 | |
| $1.670 | +0.040 | +2.5% | $1.630 | $1.720 | $1.630 | 991,100 | |
| $1.630 | -0.090 | -5.2% | $1.700 | $1.710 | $1.620 | 1,059,600 | |
| $1.720 | -0.020 | -1.1% | $1.740 | $1.750 | $1.665 | 638,400 | |
| $1.740 | 0.000 | 0.0% | $1.730 | $1.750 | $1.700 | 357,700 | |
| $1.740 | -0.010 | -0.6% | $1.760 | $1.760 | $1.700 | 526,100 | |
| $1.750 | +0.010 | +0.6% | $1.740 | $1.750 | $1.685 | 376,500 | |
| $1.740 | +0.070 | +4.2% | $1.680 | $1.755 | $1.680 | 678,200 | |
| $1.670 | -0.130 | -7.2% | $1.810 | $1.810 | $1.660 | 792,600 | |
| $1.800 | -0.040 | -2.2% | $1.840 | $1.870 | $1.780 | 563,100 | |
| $1.840 | -0.070 | -3.7% | $1.880 | $1.920 | $1.830 | 732,800 | |
| $1.910 | +0.120 | +6.7% | $1.800 | $1.950 | $1.800 | 604,800 | |
| $1.790 | +0.070 | +4.1% | $1.730 | $1.800 | $1.730 | 642,300 | |
| $1.720 | -0.070 | -3.9% | $1.770 | $1.770 | $1.700 | 655,500 | |
| $1.790 | +0.030 | +1.7% | $1.760 | $1.810 | $1.720 | 547,600 | |
| $1.760 | -0.050 | -2.8% | $1.800 | $1.860 | $1.755 | 789,300 | |
| $1.810 | -0.080 | -4.2% | $1.890 | $1.934 | $1.760 | 883,600 | |
| $1.890 | +0.030 | +1.6% | $1.860 | $1.900 | $1.756 | 974,300 | |
| $1.860 | 0.000 | 0.0% | $1.870 | $2.010 | $1.850 | 1,167,800 | |
| $1.860 | -0.550 | -22.8% | $1.750 | $1.880 | $1.540 | 4,856,500 | |
| $2.410 | +0.040 | +1.7% | $2.370 | $2.430 | $2.335 | 727,700 | |
| $2.370 | 0.000 | 0.0% | $2.380 | $2.400 | $2.320 | 660,700 | |
| $2.370 | +0.030 | +1.3% | $2.370 | $2.425 | $2.350 | 831,600 | |
| $2.340 | -0.030 | -1.3% | $2.400 | $2.450 | $2.320 | 780,600 |
- Ticker
- Stuttgart:2PQ
- Asset type
- Stock
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Oct 12, 2026
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
Latest earnings call · Aug 6, 2026
Organogenesis Holdings (NASDAQ:ORGO) Q2 2026 Earnings Call
Replay and transcript
Calls
Upcoming
Organogenesis Holdings (NASDAQ:ORGO) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 5:00 PM ET
Register
Replays
Organogenesis Holdings (NASDAQ:ORGO) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 5:00 PM ET
Watch TranscriptOrganogenesis Holdings (NASDAQ:ORGO) Q1 2026 Earnings Call
Thu, May 07, 2026 · 5:00 PM ET
Watch TranscriptOrganogenesis Holdings (NASDAQ:ORGO) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 5:00 PM ET
Watch Transcript
Latest news
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
Oct 12, 2026
Closed $1.21 (-1.6%) on Oct 13, 2026
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
Oct 12, 2026
Closed $1.21 (-1.6%) on Oct 13, 2026
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
Aug 6, 2026
Closed $1.86 (-22.8%) on Aug 7, 2026
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
Jul 27, 2026
Closed $2.53 (-0.8%) on Jul 28, 2026
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
Jul 9, 2026
Closed $2.46 (-0.4%) on Jul 9, 2026
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
Jul 6, 2026
Closed $2.50 (+0.8%) on Jul 7, 2026
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
May 7, 2026
Closed $2.37 (-6.3%) on May 8, 2026
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
Apr 28, 2026
Closed $2.40 (+0.4%) on Apr 28, 2026
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
Apr 6, 2026
Closed $2.24 (0.0%) on Apr 6, 2026
Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM
Apr 6, 2026
Closed $2.24 (0.0%) on Apr 6, 2026
Decks
Investor Presentation (March 2025)
Investor deck · 20 slides · Mar 27, 2025
Investor Presentation (December 2020)
Investor deck · 38 slides · Dec 10, 2020
Investor Presentation (September 2020)
Investor deck · 45 slides · Sep 15, 2020
Investor Presentation (August 2020)
Investor deck · 45 slides · Aug 10, 2020
Organogenesis Holdings Inc. on 6ix
- News releases
- 15 in the last 12 months · 120 in all · newest Oct 12, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Aug 6, 2026
- Decks
- 13 decks · latest Mar 27, 2025
Where Organogenesis Holdings Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ORGO · Home listing | NASDAQ | United States | USD |
| LS Exchange:A2PA31 | LS Exchange | Germany | EUR |
| BOATS:ORGO | BOATS | United States | USD |
| Lang & Schwarz:A2PA31 | Lang & Schwarz | Germany | EUR |
| gettex:2PQ | gettex | Germany | EUR |
| Tradegate:2PQ | Tradegate | Germany | EUR |
| Dusseldorf:2PQ | Dusseldorf | Germany | EUR |
| Frankfurt:2PQ | Frankfurt | Germany | EUR |
| Munich:2PQ | Munich | Germany | EUR |
| Stuttgart:2PQ · This page | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Organogenesis Holdings Inc.